| Year |
Citation |
Score |
| 2023 |
Maddison DC, Malik B, Amadio L, Bis-Brewer DM, Züchner S, Peters OM, Smith GA. COPI-regulated mitochondria-ER contact site formation maintains axonal integrity. Cell Reports. 42: 112883. PMID 37498742 DOI: 10.1016/j.celrep.2023.112883 |
0.742 |
|
| 2022 |
Rees D, Beynon AL, Lelos MJ, Smith GA, Roberts LD, Phelps L, Dunnett SB, Morgan AH, Brown RM, Wells T, Davies JS. Acyl-Ghrelin Attenuates Neurochemical and Motor Deficits in the 6-OHDA Model of Parkinson's Disease. Cellular and Molecular Neurobiology. PMID 36107359 DOI: 10.1007/s10571-022-01282-9 |
0.531 |
|
| 2021 |
Peters OM, Smith GA. A nod and a Wnk to axon branching and destruction. Neuron. 109: 2799-2802. PMID 34534451 DOI: 10.1016/j.neuron.2021.08.027 |
0.747 |
|
| 2021 |
Lin TH, Bis-Brewer DM, Sheehan AE, Townsend LN, Maddison DC, Züchner S, Smith GA, Freeman MR. TSG101 negatively regulates mitochondrial biogenesis in axons. Proceedings of the National Academy of Sciences of the United States of America. 118. PMID 33972422 DOI: 10.1073/pnas.2018770118 |
0.515 |
|
| 2021 |
Peters OM, Weiss A, Metterville J, Song L, Logan R, Smith GA, Schwarzschild MA, Mueller C, Brown RH, Freeman M. Genetic diversity of axon degenerative mechanisms in models of Parkinson's disease. Neurobiology of Disease. 105368. PMID 33892050 DOI: 10.1016/j.nbd.2021.105368 |
0.765 |
|
| 2020 |
Precious SV, Smith GA, Heuer A, Jaeger I, Lane EL, Dunnett SB, Li M, Kelly CM, Rosser AE. Dopaminergic Progenitors Derived From Epiblast Stem Cells Function Similarly to Primary VM-Derived Progenitors When Transplanted Into a Parkinson's Disease Model. Frontiers in Neuroscience. 14: 312. PMID 32317925 DOI: 10.3389/Fnins.2020.00312 |
0.774 |
|
| 2019 |
Malik BR, Maddison DC, Smith GA, Peters OM. Autophagic and endo-lysosomal dysfunction in neurodegenerative disease. Molecular Brain. 12: 100. PMID 31783880 DOI: 10.1186/S13041-019-0504-X |
0.756 |
|
| 2019 |
Smith GA, Lin TH, Sheehan AE, Van der Goes van Naters W, Neukomm LJ, Graves HK, Bis-Brewer DM, Züchner S, Freeman MR. Glutathione S-Transferase Regulates Mitochondrial Populations in Axons through Increased Glutathione Oxidation. Neuron. PMID 31101394 DOI: 10.1016/J.Neuron.2019.04.017 |
0.584 |
|
| 2016 |
Breger LS, Kienle K, Smith GA, Dunnett SB, Lane EL. Influence of chronic L-DOPA treatment on immune response following allogeneic and xenogeneic graft in a rat model of Parkinson's disease. Brain, Behavior, and Immunity. PMID 27864045 DOI: 10.1016/J.Bbi.2016.11.014 |
0.764 |
|
| 2015 |
Smith GA, Jansson J, Rocha EM, Osborn T, Hallett PJ, Isacson O. Fibroblast Biomarkers of Sporadic Parkinson's Disease and LRRK2 Kinase Inhibition. Molecular Neurobiology. PMID 26399642 DOI: 10.1007/S12035-015-9435-4 |
0.543 |
|
| 2015 |
Rocha EM, Smith GA, Park E, Cao H, Brown E, Hayes MA, Beagan J, McLean JR, Izen SC, Perez-Torres E, Hallett PJ, Isacson O. Glucocerebrosidase gene therapy prevents α-synucleinopathy of midbrain dopamine neurons. Neurobiology of Disease. PMID 26392287 DOI: 10.1016/J.Nbd.2015.09.009 |
0.583 |
|
| 2015 |
Lewis EA, Smith GA. Using Drosophila models of Huntington's disease as a translatable tool. Journal of Neuroscience Methods. PMID 26241927 DOI: 10.1016/J.Jneumeth.2015.07.026 |
0.36 |
|
| 2015 |
Rocha EM, Smith GA, Park E, Cao H, Graham AR, Brown E, McLean JR, Hayes MA, Beagan J, Izen SC, Perez-Torres E, Hallett PJ, Isacson O. Chronic pharmacological glucocerebrosidase inhibition induces α-synuclein aggregation, microglial and complement activation and synaptic protein changes in mice. Antioxidants & Redox Signaling. PMID 26094487 DOI: 10.1089/Ars.2015.6307 |
0.56 |
|
| 2015 |
Rocha EM, Smith GA, Park E, Cao H, Brown E, Hallett P, Isacson O. Progressive decline of glucocerebrosidase in aging and Parkinson's disease. Annals of Clinical and Translational Neurology. 2: 433-8. PMID 25909088 DOI: 10.1002/Acn3.177 |
0.543 |
|
| 2015 |
Smith GA, Rocha EM, Rooney T, Barneoud P, McLean JR, Beagan J, Osborn T, Coimbra M, Luo Y, Hallett PJ, Isacson O. A Nurr1 agonist causes neuroprotection in a Parkinson's disease lesion model primed with the toll-like receptor 3 dsRNA inflammatory stimulant poly(I:C). Plos One. 10: e0121072. PMID 25815475 DOI: 10.1371/Journal.Pone.0121072 |
0.602 |
|
| 2015 |
Hallett PJ, Deleidi M, Astradsson A, Smith GA, Cooper O, Osborn TM, Sundberg M, Moore MA, Perez-Torres E, Brownell AL, Schumacher JM, Spealman RD, Isacson O. Successful function of autologous iPSC-derived dopamine neurons following transplantation in a non-human primate model of Parkinson's disease. Cell Stem Cell. 16: 269-74. PMID 25732245 DOI: 10.1016/J.Stem.2015.01.018 |
0.624 |
|
| 2014 |
McLean JR, Smith GA, Rocha EM, Osborn TM, Dib S, Hayes MA, Beagan JA, Brown TB, Lawson TF, Hallett PJ, Robertson J, Isacson O. ALS-associated peripherin spliced transcripts form distinct protein inclusions that are neuroprotective against oxidative stress. Experimental Neurology. 261: 217-29. PMID 24907400 DOI: 10.1016/J.Expneurol.2014.05.024 |
0.508 |
|
| 2014 |
McLean JR, Smith GA, Rocha EM, Hayes MA, Beagan JA, Hallett PJ, Isacson O. Widespread neuron-specific transgene expression in brain and spinal cord following synapsin promoter-driven AAV9 neonatal intracerebroventricular injection. Neuroscience Letters. 576: 73-8. PMID 24882721 DOI: 10.1016/J.Neulet.2014.05.044 |
0.534 |
|
| 2014 |
Smith GA, Rocha EM, McLean JR, Hayes MA, Izen SC, Isacson O, Hallett PJ. Progressive axonal transport and synaptic protein changes correlate with behavioral and neuropathological abnormalities in the heterozygous Q175 KI mouse model of Huntington's disease. Human Molecular Genetics. 23: 4510-27. PMID 24728190 DOI: 10.1093/Hmg/Ddu166 |
0.575 |
|
| 2014 |
Davies SE, Hallett PJ, Moens T, Smith G, Mangano E, Kim HT, Goldberg AL, Liu JL, Isacson O, Tofaris GK. Enhanced ubiquitin-dependent degradation by Nedd4 protects against α-synuclein accumulation and toxicity in animal models of Parkinson's disease. Neurobiology of Disease. 64: 79-87. PMID 24388974 DOI: 10.1016/J.Nbd.2013.12.011 |
0.607 |
|
| 2013 |
Sundberg M, Bogetofte H, Lawson T, Jansson J, Smith G, Astradsson A, Moore M, Osborn T, Cooper O, Spealman R, Hallett P, Isacson O. Improved cell therapy protocols for Parkinson's disease based on differentiation efficiency and safety of hESC-, hiPSC-, and non-human primate iPSC-derived dopaminergic neurons. Stem Cells (Dayton, Ohio). 31: 1548-62. PMID 23666606 DOI: 10.1002/Stem.1415 |
0.59 |
|
| 2013 |
Peters OM, Shelkovnikova T, Tarasova T, Springe S, Kukharsky MS, Smith GA, Brooks S, Kozin SA, Kotelevtsev Y, Bachurin SO, Ninkina N, Buchman VL. Chronic administration of Dimebon does not ameliorate amyloid-β pathology in 5xFAD transgenic mice. Journal of Alzheimer's Disease : Jad. 36: 589-96. PMID 23645096 DOI: 10.3233/Jad-130071 |
0.735 |
|
| 2013 |
Heuer A, Smith GA, Dunnett SB. Comparison of 6-hydroxydopamine lesions of the substantia nigra and the medial forebrain bundle on a lateralised choice reaction time task in mice. The European Journal of Neuroscience. 37: 294-302. PMID 23113688 DOI: 10.1111/Ejn.12036 |
0.67 |
|
| 2012 |
Smith GA, Heuer A, Klein A, Vinh NN, Dunnett SB, Lane EL. Amphetamine-induced dyskinesia in the transplanted hemi-Parkinsonian mouse. Journal of Parkinson's Disease. 2: 107-13. PMID 23933747 DOI: 10.3233/Jpd-2012-12102 |
0.776 |
|
| 2012 |
Smith GA, Isacson O, Dunnett SB. The search for genetic mouse models of prodromal Parkinson's disease. Experimental Neurology. 237: 267-73. PMID 22819262 DOI: 10.1016/J.Expneurol.2012.06.035 |
0.663 |
|
| 2012 |
Smith GA, Breger LS, Lane EL, Dunnett SB. Pharmacological modulation of amphetamine-induced dyskinesia in transplanted hemi-parkinsonian rats. Neuropharmacology. 63: 818-28. PMID 22722025 DOI: 10.1016/J.Neuropharm.2012.06.011 |
0.771 |
|
| 2012 |
Smith GA, Dunnett SB, Lane EL. Amphetamine-induced rotation in the transplanted hemi-parkinsonian rat--response to pharmacological modulation. Behavioural Brain Research. 232: 411-5. PMID 22516841 DOI: 10.1016/J.Bbr.2012.04.003 |
0.726 |
|
| 2012 |
Heuer A, Smith GA, Lelos MJ, Lane EL, Dunnett SB. Unilateral nigrostriatal 6-hydroxydopamine lesions in mice I: motor impairments identify extent of dopamine depletion at three different lesion sites. Behavioural Brain Research. 228: 30-43. PMID 22146593 DOI: 10.1016/J.Bbr.2011.11.027 |
0.773 |
|
| 2012 |
Smith GA, Heuer A, Dunnett SB, Lane EL. Unilateral nigrostriatal 6-hydroxydopamine lesions in mice II: predicting l-DOPA-induced dyskinesia. Behavioural Brain Research. 226: 281-92. PMID 21946310 DOI: 10.1016/J.Bbr.2011.09.025 |
0.767 |
|
| 2011 |
Torres EM, Lane EL, Heuer A, Smith GA, Murphy E, Dunnett SB. Increased efficacy of the 6-hydroxydopamine lesion of the median forebrain bundle in small rats, by modification of the stereotaxic coordinates. Journal of Neuroscience Methods. 200: 29-35. PMID 21723319 DOI: 10.1016/J.Jneumeth.2011.06.012 |
0.753 |
|
| 2011 |
Lane EL, Daly CS, Smith GA, Dunnett SB. Context-driven changes in L-DOPA-induced behaviours in the 6-OHDA lesioned rat. Neurobiology of Disease. 42: 99-107. PMID 21220017 DOI: 10.1016/J.Nbd.2011.01.010 |
0.712 |
|
| 2011 |
Smith GA, Heuer A. 6-OHDA toxin model in mouse Neuromethods. 61: 281-297. DOI: 10.1007/978-1-61779-298-4_14 |
0.565 |
|
| 2010 |
Lane EL, Smith GA. Understanding graft-induced dyskinesia. Regenerative Medicine. 5: 787-97. PMID 20868333 DOI: 10.2217/Rme.10.42 |
0.685 |
|
| Show low-probability matches. |